Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
786 studies found for:    pharmacogenomics OR pharmacogenetics
Show Display Options
Rank Status Study
21 Completed EFV Pharmacokinetics & Pharmacogenomics in Older HIV-infected Patients
Condition: HIV Infection
Intervention: Drug: Efavirenz
22 Completed Pharmacogenetics of Remifentanil in Patients With Hypertension Undergoing Cesarean Delivery Under General Anesthesia
Conditions: Pregnancy;   Cesarean Delivery;   General Anesthesia
Intervention: Drug: Remifentanil
23 Completed
Has Results
Personalized Medicine Interface Tool (PerMIT): Warfarin: A Trial Comparing Usual Care Warfarin Initiation to PerMIT Pharmacogenetic Guided Warfarin Therapy
Condition: Blood Clotting
Interventions: Genetic: warfarin pharmacogenetic dosing;   Drug: Warfarin
24 Unknown  Prediction of Antidepressant Response Using Pharmacogenetics and Peripheral Lymphocytic Phenotype
Condition: Depression
Intervention: Drug: antidepressants
25 Completed CYP2D6 Pharmacogenetics in Risperidone-Treated Children
Conditions: Psychiatric Disorders;   Neurodevelopmental Disorders
26 Completed
Has Results
First Year Growth Response Associated Genetic Markers Validation Phase IV Open-label Study in Growth Hormone Deficient and Turner Syndrome Pre-pubertal Children: the PREDICT Pharmacogenetics Validation Study
Conditions: Idiopathic Growth Hormone Deficiency;   Turner Syndrome
Intervention: Other: Blood sampling
27 Completed
Has Results
Pharmacogenomic Evaluation of Antihypertensive Responses
Condition: Hypertension
Interventions: Drug: HCTZ + atenolol;   Drug: Atenolol + HCTZ
28 Unknown  Pharmacogenomics of Thiazolidinediones
Condition: Type 2 Diabetes
Intervention: Drug: Pioglitazone
29 Completed
Has Results
Study of Medical Treatment for Methamphetamine Addiction
Conditions: Methamphetamine;   Amphetamine Dependence;   Pharmacogenetics;   Methamphetamine Dependence;   Substance Abuse
Intervention: Drug: Bupropion
30 Recruiting Assessing the Clinical Benefits of a Pharmacogenetics-Guided Dosing Regiment for Calculating Warfarin Maintenance Dose
Condition: Indications for Warfarin Therapy
Intervention: Drug: Warfarin Sodium
31 Recruiting Pharmacogenomic Testing Of the Elderly To Reduce Morbidity
Condition: Genetics of Drug Metabolism
32 Completed
Has Results
Clopidogrel Pharmacogenomics Project
Condition: Disease Susceptibility
Interventions: Drug: clopidogrel 75 mg;   Drug: Clopidogrel 150 mg
33 Completed Pharmacogenomics of Paclitaxel in Ovarian Cancer
Conditions: Ovarian Neoplasms;   Fallopian Tube Neoplasms
34 Active, not recruiting Pharmacogenetics of b2-Agonists in Asthma.
Condition: Asthma
Intervention: Drug: salmeterol
35 Recruiting Validation of International Warfarin Pharmacogenetics Consortium (IWPC) Algorithm in Elderly Patients With Comorbidity
Conditions: Atrial Fibrillation;   Thrombus Due to Heart Valve Prosthesis
Intervention: Drug: Warfarin
36 Completed Pharmacogenomics of Paclitaxel in Ovarian Cancer
Conditions: Ovarian Neoplasms;   Fallopian Tube Neoplasms
37 Active, not recruiting Pharmacogenetics, Emotional Reactivity and Smoking
Conditions: Tobacco Use Disorder;   Smoking Cessation
Interventions: Drug: Bupropion;   Drug: Varenicline;   Drug: Placebo;   Behavioral: Smoking Cessation Counseling
38 Completed Clinical Pharmacogenomics of Antidepressant Response
Condition: Depression
Interventions: Drug: Paroxetine (Seroxat);   Drug: Escitalopram (Lexapro)
39 Terminated Pharmacogenomics of Anti-platelet Intervention-2 (PAPI-2) Study
Conditions: Cardiovascular Diseases;   Acute Coronary Syndrome
Interventions: Drug: clopidogrel;   Drug: prasugrel
40 Active, not recruiting Medication Therapy Management With Pharmacogenetic Testing
Conditions: Pharmacogenetics;   Medication Therapy Management
Intervention: Other: MTM with PGx

First Page    Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-60) Show next page of results    Last Page
Indicates status has not been verified in more than two years